Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-powered chronic care management platform that automates patient communication and follow-up for health systems.
Memora Health is a San Francisco-based care enablement company that provides health systems with an AI platform to automate patient communication, care navigation, and chronic disease management between clinical visits. The platform uses conversational AI delivered via SMS to check in with patients, answer frequently asked questions, capture symptom reports, and escalate concerning findings to clinical staff — extending care team capacity without adding headcount. Memora targets chronic condition management programs including oncology, cardiovascular care, behavioral health, and pregnancy, where consistent patient monitoring between visits improves outcomes and reduces preventable hospitalizations. The platform integrates with EHR systems and enables care coordinators to manage larger patient panels by automating the routine communication that consumed their time. Founded in 2017, Memora raised over $80M from investors including General Catalyst, Andreessen Horowitz, and Kaiser Permanente Ventures. It competes with Luma Health and Welkin Health in the patient engagement and care management platform market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.